Installation Instructions Part 1

Table Of Contents
Description of the Medtronic MiniMed 2007C Implantable Insulin Pump System
16
Radio-Opaque Identification the Implantable Insulin Pump features
radio-opaque identification. In the event of an emergency, the name
of the manufacturer and the Pump model number can be identified
with an x-ray.
Insulin medication
Only Aventis HOE 21 PH U-400 insulin can be used with the Medtronic
MiniMed 2007C Implantable Insulin Pump System.
HOE 21 PH U-400 is a highly purified, semi-synthetic human insulin
with 0.2% phenol as a preserving agent, glycerol as an isotonic compo-
nent, TRIS as a buffer, plus zinc and Genapol
®
as stabilizing agents.
HOE 21 PH U-400 is equivalent in mode of action to normal (soluble)
insulin. A special U-400 insulin concentration has been developed for use
in the Implantable Insulin Pump and is supplied in 10mL vials (400U/
mL) from Aventis.
Side Port Catheter
The Side Port Catheter (Catheter) transports insulin from the Pump into
an individual’s peritoneum where it is absorbed. The Catheter is made of
polyethylene-lined silicone rubber, which is biocompatible with subcuta-
neous and intraperitoneal tissues and supports the stability of the special
insulin. The Catheter is designed with two perpendicular sections: a
proximal subcutaneous section which attaches tangentially to the Pump
with a locking connector, and a distal section which is placed in the peri-
toneum (see Figure 4). To enable post-implant localization, a radioopaque
stripe runs the length of the Catheter.
Dmp9196021-011_c.book Page 16 Thursday, April 4, 2002 8:15 AM